載入...
Pembrolizumab-Associated Seronegative Myasthenia Gravis in a Patient With Metastatic Renal Cell Carcinoma
Seronegative myasthenia gravis is a rare, but potential adverse effect of immune checkpoint inhibition. There have been few but increasing number of cases reported in recent years, and early recognition is important for prompt diagnosis and management. Here, we describe the case of a 65-year-old mal...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216640/ https://ncbi.nlm.nih.gov/pubmed/34178496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.15174 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|